GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B1064 L-(-)-α-Methyldopa (hydrate)Summary: Alpha-adrenergic agonist
- B2261 ZolmitriptanSummary: Potent 5-HT1B/1D/1F agonist
- B2081 MeprednisoneSummary: Glucocorticoid receptor (GR) agonist
- B2158 DesonideSummary: nonfluorinated corticosteroid anti-inflammatory agent
- B1951 HydrocortisoneSummary: steroid hormone or glucocorticoid
- B1330 Acebutolol HClSummary: β-adrenergic receptors antagonist
- B1331 Adrenalone HClSummary: Adrenergic receptor agonist
- B1427 AM251Target: CB1 ReceptorsSummary: Potent CB1 antagonist
- B2231 Amitriptyline HClTarget: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT TransportersSummary: Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor
- B1353 Betaxolol HClSummary: β1 adrenergic receptor blocker